Advocacy

From May to July 2025, through letters to HHS, CMS, FDA, and OMB, as well as submissions through CMS and OMB portals, AAPA identified numerous regulatory and policy barriers that arbitrarily and unjustifiably limit PA practice and impose administrative burdens.

In June 2025, AAPA submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the topics of hospice, skilled nursing facilities, inpatient rehabilitation facilities, and inpatient psychiatric facilities. These comments, in response to annually released proposed rules that make adjustments to the hospice wage index and respective fee schedules, responded directly to inquiries made within the rules, as well as identified policy obstacles faced by PAs in these settings.

In May 2025, AAPA submitted comments to the Department of Justice (DOJ) and the Federal Trade Commission (FTC) in response to separate, but similar, requests for information (RFIs) regarding the topic of anticompetitive laws and regulations at both the state and federal levels. These comments directly addressed inquiries made within the RFIs and identified obstacles faced by PAs due to anticompetitive measures.